CliffBio
small molecule

TRAVASOL 8.5% IN PLASTIC CONTAINER

AMINO ACIDS

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRAVASOL 8.5% IN PLASTIC CONTAINER
Active ingredientAMINO ACIDS
Strength8.5% (8.5GM/100ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 1984
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.